1. OPUS

Auflistung nach Institut Institut für Zellbiologie und Immunologie

Gehe zu: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
oder geben Sie die Anfangszeichen ein:  
Anzeige der Treffer 85 bis 104 von 136 < zurück   nächste
ErscheinungsdatumTitelAutor(en)
2008Neue TRAIL-Varianten für die zielgerichtete TumortherapieSchneider, Britta
2018Novel EGFR family member binding antibodies as cancer therapeuticsSchmitt, Lisa
2009Novel electrokinetic approaches to improve purification processes with monoclonal antibodiesFaude, Alexander
2022Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatmentHeine, Simon
2022Overcoming glioblastoma intractability : pre-clinical characterisation of TRAIL sensitisation by marizomib and novel treatment perspectivesBoccellato, Chiara
2021Pharmacokinetic engineering of OX40-blocking anticalin proteins using monomeric plasma half-life extension domainsSiegemund, Martin; Oak, Prajakta; Hansbauer, Eva-Maria; Allersdorfer, Andrea; Utschick, Karoline; Winter, Alexandra; Grasmüller, Christina; Galler, Gunther; Mayer, Jan-Peter; Weiche, Benjamin; Prassler, Josef; Kontermann, Roland E.; Rothe, Christine
2010Phenocopy : a strategy to qualify chemical compounds during hit-to-lead and/or lead optimizationBaum, Patrick
2014Population and single-cell based quantitative analysis of protein kinase D-mediated regulation of the cell cycleRäth, Sebastian
2020Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical modelTsur, Neta
2023Prognostication and prediction of cancer patient outcomes using AI-based classifiersGuttà, Cristiano
2021Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosolHellwig, Christian T.; Delgado, M. Eugenia; Skoko, Josip; Dyck, Lydia; Hanna, Carol; Wentges, Alexa; Langlais, Claudia; Hagenlocher, Cathrin; Mack, Alexandra; Dinsdale, David; Cain, Kelvin; MacFarlane, Marion; Rehm, Markus
2008Protein kinase D (PKD) mouse models – towards an understanding of the physiological role of PKDEllwanger, Kornelia
2012Protein Kinase D controls mitotic Golgi complex fragmentation through a RAF-MEK1 pathwayKienzle, Christine
2019Prozessentwicklung zur Produktion und Reinigung eines PEGylierten AntikörperfragmentesLindner, Robert
2017RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaksRommel, Philipp Christian
2020Rapid target binding and cargo release of activatable liposomes bearing HER2 and FAP single-chain antibody fragments reveal potentials for image-guided delivery to tumorsTansi, Felista L.; Rüger, Ronny; Böhm, Claudia; Steiniger, Frank; Raasch, Martin; Mosig, Alexander S.; Kontermann, Roland E.; Teichgräber, Ulf K.; Fahr, Alfred; Hilger, Ingrid
2013Reaktion Tumor-assoziierter Fibroblasten aus Lungenkarzinomen auf Kinase-Inhibitoren und Chemotherapeutika in verschiedenen KulturmodellenHaubeiß, Silke
2021Regulation of basal and activity-mediated AMPAR endocytosis by Protein Kinase D (PKD)Oueslati Morales, Carlos Omar
2015Regulation of endocytic membrane trafficking by the GTPase-activating protein Deleted in Liver Cancer 3 (DLC3)Braun, Anja Catharina
2009Regulation of START domain containing proteins through membrane interactionErlmann, Patrik
Anzeige der Treffer 85 bis 104 von 136 < zurück   nächste